Lunsekimig Evidence: Trial Results and Peer-Reviewed Publications

Hipa.ai Research · Source: PubMed & ClinicalTrials.gov / AACT · Last updated:

The clinical evidence base for Lunsekimig comprises 1 peer-reviewed publications across 1 journals, 0 pivotal-trial primary-outcome rows reported to ClinicalTrials.gov, spanning indications including Asthma. Most recent publication: Novel asthma treatments: Advancing beyond approved novel step-up therapies for asthma., Ann Allergy Asthma Immunol, 2025.

Top peer-reviewed publications

Curated set of pivotal-trial result papers and recent publications in high-tier journals.

  1. Novel asthma treatments: Advancing beyond approved novel step-up therapies for asthma.
    Seluk L, Davis AE, Rhoads S, et al. · Ann Allergy Asthma Immunol · 2025

Publications by year

20252025: 1 publications.

2025
1

Publications by indication

Asthma (1)

  • Novel asthma treatments: Advancing beyond approved novel step-up therapies for asthma.
    Ann Allergy Asthma Immunol · 2025 · PMID 39393433 · NCT06102005

Publications by journal

All Lunsekimig publications (1)

2025 (1 paper)

  1. Novel asthma treatments: Advancing beyond approved novel step-up therapies for asthma.
    Seluk L, Davis AE, Rhoads S, et al. · Ann Allergy Asthma Immunol · 2025 · Derived

Sources and methodology

This page summarizes published evidence for general reference and does not constitute medical advice. For clinical decisions, consult the linked primary publications and your healthcare provider. Data sourced from PubMed and the ClinicalTrials.gov / AACT database maintained by the Clinical Trials Transformation Initiative (CTTI).